Table 4.4 Reported cases of laboratory-confirmed, hepatitis C (past or present) infection, by sex, race/ethnicity, age group, and positive lab tests — Emerging Infections Program (EIP), Hepatitis Surveillance Demonstration Sites, 2011
Category | CO No. (%) | CT No. (%) | MN No. (%) | NM No. (%) | NY State No. (%) | NY City No. (%) | OR No. (%) | San Francisco No. (%) | Total No. (%) |
---|---|---|---|---|---|---|---|---|---|
Sex | |||||||||
Female | 1030 (35.5) | 957 (33.0) | 649 (36.0) | 884 (31.8) | 2467 (35.8) | 3146 (36.0) | 1639 (36.4) | 526 (27.1) | 11298 (34.8) |
Male | 1864 (64.3) | 1940 (66.9) | 1142 (63.4) | 1897 (68.2) | 4408 (63.9) | 5595 (64.0) | 2865 (63.6) | 1418 (72.9) | 21129 (65.1) |
Unknown/Miss | 4 (0.1) | 1 (0.0) | 11 (0.6) | 0 (0.0) | 23 (0.3) | 8 (0.1) | 0 (0.0) | 0 (0.0) | 47 (0.1) |
Race/Ethnicity* | |||||||||
AI / AN | 24 (0.8) | 5 (0.2) | 97 (5.4) | 46 (1.7) | 28 (0.4) | 0 (0.0 ) | 63 (1.4) | 13 (0.7) | 276 (0.8) |
API | 16 (0.6) | 25 (0.9) | 50 (2.8) | 3 (0.1) | 59 (0.9) | 171 (2.0) | 46 (1.0) | 72 (3.7) | 442 (1.4) |
Black | 143 (4.9) | 311 (10.7) | 203 (11.3) | 12 (0.4) | 614 (8.9) | 927 (10.6) | 105 (2.3) | 366 (18.8) | 2681 (8.3) |
White | 992 (34.2) | 1222 (42.2) | 737 (40.9) | 283 (10.2) | 2284 (33.1) | 667 (7.6) | 1964 (43.6) | 624 (33.1) | 8773 (27.0) |
Hispanic | 323 (11.2) | 506 (17.5) | 40 (2.2) | 419 (15.1) | 434 (6.3) | 306 (3.5) | 87 (1.9) | 148 (7.6) | 2263 (7.0) |
Other | 21 (0.7) | 5 (0.2) | 9 (0.5) | 0 (0.0) | 64 (0.9) | 287 (3.3) | 13 (0.3) | 37 (1.9) | 436 (1.3) |
Unknown / Missing | 1379 (47.6) | 824 (28.4) | 666 (37.0) | 2018 (72.6) | 3415 (49.5) | 6391 (73.1) | 2226 (49.4) | 684 (35.3) | 17603 (54.2) |
Age group (yrs) | |||||||||
0-14 | 11 (0.4) | 8 (0.3) | 5 (0.3) | 10 (0.4) | 12 (0.2) | 42 (0.5) | 5 (0.1) | 4 (0.2) | 97 (0.3) |
15-24 | 121 (4.2) | 143 (4.9) | 126 (7.0) | 363 (13.1) | 416 (6.0) | 298 (3.4) | 142 (3.2) | 34 (1.8) | 1643 (5.1) |
25-39 | 613 (21.2) | 597 (20.6) | 316 (17.5) | 923 (33.2) | 1337 (19.4) | 1629 (18.6) | 655 (14.5) | 242 (12.5) | 6312 (19.4) |
40-54 | 1198 (41.3) | 1218 (42.0) | 729 (40.5) | 938 (33.7) | 2352 (34.1) | 3035 (34.7) | 1980 (44.0) | 715 (36.8) | 12165 (37.5) |
55+ | 948 (32.7) | 932 (32.2) | 626 (34.7) | 547 (19.7) | 2753 (39.9) | 3744 (42.8) | 1719 (32.8) | 948 (48.8) | 12217 (37.6) |
Missing | 7 (0.2) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 28 (0.4) | 1 (0.0) | 3 (0.3) | 2 (0.2) | 40 (0.1) |
Positive Laboratory Tests† | |||||||||
RIBA | 279 (9.6) | 94 (3.2) | 367 (20.4) | U (U) | 746 (10.8) | 1117 (12.8) | 300 (6.7) | 23 (1.2) | 2926 (9.0) |
HCV RNA | 1574 (54.3) | 743 (25.6) | 1315 (73.0) | U (U) | 3664 (53.1) | 4357 (49.8) | 2036 (45.2) | 1294 (66.6) | 14983 (46.1) |
Genotype | 695 (24.0) | 89 (3.1) | 626 (34.8) | U (U) | 1494 (22.6) | 2582 (29.5) | 656 (14.8) | 538 (27.7) | 6680 (20.6) |
Anti-HCV and s/co ratio | 1721 (59.4) | 2360 (81.4) | 534 (29.6) | U (U) | 3198 (46.4) | 7001 (80.0) | 1155 (25.6) | 1250 (64.3) | 17219 (53.0) |
Total new reported cases | 2,898 | 2,898 | 1,802 | 2,781 | 6,898 | 8,749 | 4,504 | 1,944 | 32,474 |
Estimated 2010 population | 5,116,796 | 3,580,709 | 5,344,861 | 2,082,224 | 11,220,287 | 8,244,910 | 3,871,859 | 812,826 | 40,274,472 |
Rate per 100,000 population | 57 | 81 | 34 | 134 | 61 | 106 | 116 | 239 | 81 |
*Categorized in the following order: 1) Hispanic; 2) AI/AN; 3) API; 4) Black; 5) White; 6) Other;
† Cases can be reported with more than one laboratory test result
U=No data available for reporting.
- Page last reviewed: August 19, 2013
- Page last updated: August 19, 2013
- Content source: